{
  "url": "https://openlegislation.uk/misuse-of-drugs-designation-england-wales-and-scotland-order-2015/schedule-1/paragraph-9",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-designation-england-wales-and-scotland-order-2015/schedule-1/paragraph-9.json",
  "legislation": "uksi/2015/704",
  "legislation_title": "The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-designation-england-wales-and-scotland-order-2015",
  "path": "schedule/1/paragraph/9",
  "kind": "paragraph",
  "number": "9",
  "heading": null,
  "text": "A liquid formulation—\n(a) containing a botanical extract of cannabis—\n(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and\n(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,\n(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and\n(c) which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on the 16th June 2010.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 1 para. 9 in force at 31.5.2015, see art. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2015/704/schedule/1/paragraph/9",
    "retrieved_at": "2026-10-28T23:42:31.140777+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}